In a note in August, Goldman Sachs analysts forecasted that pills will capture a 24% share or around $22 billion of the 2030 global weight loss drug market, which they expect to be worth $95 billion in total
Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C
not a controlled trial
Approved by the FDA on 1 April 2026, it is the only oral GLP-1 receptor agonist that can be taken at any time of day without food or water restrictions, distinguishing it from oral Wegovy, which must be taken in the morning on an empty stomach
With todays approval, adolescents and adults who struggle with substantial hair loss have an opportunity to achieve significant scalp hair regrowth. The study was published in The Lancet
We have unique settings on our Fraxel laser as well as pico & nano lasers to help improve skin colour, clarity and collagen